Serum concentrations of soluble intercellular adhesion molecules, sICAM-I , sICAM-3 and sP-selectin, of serum soluble cytokine receptors, sIL-2R, and sTNF-R55 and of neopterin were measured by commercially available immunoassays in 35 patients with rheumatoid arthritis (RA). Serum sICAM-I, sICAM-3 and sPselectin were significantly elevated in patients with RA compared with healthy controls. Concentrations of sPselectin and sICAM-3 correlated with disease activity and severity indices . sICAM-3 levels significantly correlated with sTNF-R55 and neopterin. There were significant correlations between neopterin and sIL-2R and between sTNF-R55 and sIL-2R. The measurement of sP-selectin and sICAM-3 levels in patients with RA might become useful for monitoring disease activity.
Introduction
Immune system activation and associated cascades of pro-and anti-inflammatory cytokines are deeply involved in the pathogenesis of rheumatoid arthritis. Expression of cell adhesion molecules is upregulated (or induced) by pro-inflammatory cytokines, and may have a central role in the mechanism of immunemediated inflammation. They regulate migration of leukocytes through blood vessels and their retention in the inflamed tissue, and they provide costimulatory signals for leukocytes activation and lymphocyte proliferation (1, 2) . Rheumatoid arthritis (RA) is a chronic inflammatory disease of the joint, often associated with systemic (extraarticular) manifestations (3) . The excessive production of proinflammatory cytokines such as tumor necrosis factor-(TNF)-a, interleukin-(IL )-1, IL-6, IL-8 (4, 5) leads to hyperexpression of cell adhesion mo lecules on endothelial cells (EC) and leukocytes (6) (7) (8) . This mechanism could be crucial in the pathogenesis of RA. In recent years soluble isoforms of several types of cellular adhesion molecules have been described (9) . These soluble cellular adhesion molecules lack transmembrane and intracellular domains, but extracellular portions are released from cell surface by enzymatic cleavage, or may be formed and secreted by cells by alternative splicing of mRNA. Several studies have demonstrated elevated levels of soluble intercellular adhesion molecules (sICAM) in various PteridinesNol. 11INo. 2 infectious, neoplastic and autoimmune diseases (9) (10) (11) . It also has been hypothesized that soluble adhesion molecules can be regarded as an index of endothelial and/or leukocyte activation and can be used as markers of disease activity in different disease state. The monitoring of RA is based on clinical observation and determination of conventional parameters of inflammation, such as C-reactive protein (CRP), serum iron and hemoglobin levels and erythrocyte sedimentation rate (ESR) (12) . More recently, it has been demonstrated that serum levels of markers of cell mediated immune activation such as soluble interleukin-2 receptors (sIL-2R) (13) (14) (15) (16) (17) (18) , tumor necrosis factor receptors (sTNF-R) (16, 17, 19) and neopterin (20, 21) are raised in patients with RA and the concentrations correlated well with disease activity variables. At last, the clinical significance of soluble adhesion molecules in RA has become the focus of considerable attention. Several previous reports have shown increased levels of sICAM-l (22-29), sICAM-3 (29-31) and sP-selectin (29, 32) in RA, however in some cases the data are contradictory especially regarding the correlations with disease activity. In this study, we measured circulating levels of soluble adhesion molecules, sICAM-l, sICAM-3 and P-selectin, in patients with RA. Our aim was to assess whether 1. the concentrations reflect disease activity, 2. correlate with each other and 3. whether they correlate with serum markers of immune activation. (36) . Disease activity index includes the following 4 parameters: pain (none -score 0, intermittent -score 1, constant -score 2), duration (min) of early morning stiffness «15 -score 0, 15-30 -score 1, >30 -score 2), total count of swollen andlor tender joints (0-2 -score 0,3-5 -score 1, >5 -score 3); ESR (mmIh): <30 -score 0, 30-45 -score I, >35 -score 2). Total maximum score = 8. Severity disease index is calculated by adding the prognostic factors to the disease activity score: Prognostic factors include the following parameters: deteriorating functional capacity during previous 6 months -score 1; sustained (> 6 months) elevated ESR (> 30 nun/h) -score 1; rheumatoid factor titer (> 1 :640 latex); extraarticular disease (rheumatoid nodules, inflammatory eye disease, sicca complex, vasculitis, and pleural or pulmonary disease -score -1. Total maximum score = 5. Some of these clinical parameters of RA patients are described in Table 1 . sICAM-I , sICAM-3 and sP-selectin concentrations were determined by commercially available sandwich ELISAs (Bender MedSystems, Vienna, Austria). Also serum neopterin (BRAHMS, Berlin, Germany) and concentrations of soluble tumor necrosis factor type I (55 kDa) receptors (sTNF-R55) and sIL2-R were determined by ELISAs (T-Cell Sciences, Cambridge, MA, USA). The procedure was performed according to the manufacturers' instructions. Normal values (95% confidence interval) in control samples from healthy adults using these assays in our laboratory were as follows sICAM-I : 130 -297 ng/mI, sICAM-3 : 29 -72 .5 ng/mI, sP-selectin: III -266 ng/mI, sTNF- Results A significant proportion of the patients with RA had increased serum concentrations of slCAM compared with the normal range established in healthy subjects. We found abnormal values (>mean + 2 S.D. of control values) for sICAM-I in 26/35 patients (= 74.2%), sICAM-3 (10/35 = 28.6%) and sP-selectin in (9/34 = 25.7%). We did not observe any significant difference in slCAM concentrations between patients who were or were not taking steroids. The associations between the main clinical and laboratory parameters with slCAM are shown in Table  2 . A positive correlation was obtained between sPselectin concentrations and effusion count, disease activity index and disease severity index, and there was a tendency for joint count. sICAM-3 was also positively correlated with effusion count, disease activity, severity indices and in addition with ESR. sICAM-l levels inversely correlated with disease duration. There were significant correlations of sICAM-3 with sTNF-R55 (rs = 0.462, P <0.01) and neopterin (rs = 0.410, P <0.05) and between sIL-2R and sTNF-R55 (rs = 0.490, P <0.01). There existed also strong PteridinesNol. IIINo. 2 authors (29) . Serum levels of P-selectin correlate with clinical disease activity in patients with scleroderma (38) . Recently it has been suggested that sP-selectin is a marker of platelet but not endothelial cell activation (39) . Platelets has been implicated in the pathogenesis of RA as well (40) . However, we failed to fmd any correlations between sP-selectin and both von Willebrand factor concentrations and platelet counts. Hence, the main source of sP-selectin merits future evaluation. In contrast to most other members of Ig-superfamily, ICAM-3 is primarily expressed on resting and activated lymphocytes. ICAM-3 has costimulatory functions and may be particularly involved in InItlatmg immune response. Significantly elevated levels of slCAM have been shown in several autoimmune disease such as systemic lupus erythematosus (SLE), multiple sclerosis, GuilllianBarre syndrome (30) . The correlations found between sICAM-3 concentrations and RA activity, severity mdices and ESR confirms and extends the results of other authors who revealed elevated levels sICAM-3 m patients with RA (27, 29, 30) . Our results extend recent data demonstrating increased serum concentrations of sIL-2R, sTNF-R and neopterin in patients with RA. Regarding the soluble cytokine receptor levels, our results are in agreement with others who found weak or no correlations between sIL-2R and sTNF-R levels and disease activity in RA patients (13, 16, 18) . It is mteresting that serum neopterin concentrations correlated more closely with disease activity and severity and especially ESR as compared with sIL-2R and sTNF-R55 . Other important findings from our studies are the significant correlations between sICAM-3, neopterin and sTNF-R55, which indicate that increased concentrations of sICAM-3 may be alternative markers of cell-mediated immune activation in RA. There are multiple potential roles of adhesion molecules in the pathophysiology of RA , including inflammatory cell attachment to endothelial cells, transendothelial migration of inflammatory cells into synovium, cytokine activation and upregulation, induction of angiogenesis etc. (8) . Endothelial cells in RA synovium have been shown to express elevated levels of P-selectin (41) and ICAM-l (42) (43) (44) . In RA synovial tissue macrophages express elevated ICAM-3 (44, 45) and monocyte adhesion to frozen section of RA synovium was strongly inhibited by monoclonal antibodies to P-selectin (46) . However, the pathophysiologic role of siC AM in RA remains unclear. They may simply reflect the immuneendothelial activation during inflammation or even modulate autoimmune reactions (30) . In summary, our study demonstrates that serum concentrations of sP-selectin and sICAM-3 correlates with clinical and laboratory indices of inflammatory activity in RA. From the practical point of view the determination of sP-selectin and neopterin might be useful for evaluation of patients with RA . An additional prospective study should be carried out to support this suggestion.
